Stay updated on Upadacitinib in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib in Atopic Dermatitis Clinical Trial page.

Latest updates to the Upadacitinib in Atopic Dermatitis Clinical Trial page
- Check7 days agoChange DetectedAn NIH-wide notice about website terminology changes was added, and the site revision advanced from v3.7.1 to v3.7.2. The page continues to display a 403 Forbidden message instead of the study record.SummaryDifference1%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check28 days agoChange DetectedA 403 Forbidden error page is now shown in place of the study record, with the site header/footer visible and a Home link available, indicating restricted access rather than the study details.SummaryDifference0.5%

- Check35 days agoChange DetectedA large set of ancillary sections and resource links were deleted from the page, including Related Info, sponsor/affiliations (AbbVie), and entries for study documents and IPD sharing. The complete list of locations and the locations section were removed, reducing visibility of participating sites.SummaryDifference20%

- Check42 days agoChange DetectedA new Revision: v3.7.0 was added to the revision history, and the previous Revision: v3.6.6 was removed, updating the page's revision record.SummaryDifference0.0%

- Check56 days agoChange DetectedThe study record was updated to revision v3.6.6, indicating a new version of the ClinicalTrials.gov entry with likely administrative or QC updates to the record.SummaryDifference0.0%

Stay in the know with updates to Upadacitinib in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib in Atopic Dermatitis Clinical Trial page.